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The development of therapeutic strategies to inhibit reactive oxygen species (ROS)-mediated damage in blood vessels has been limited by a lack of specific targets for intervention.
Targeting ROS-mediated events in the vessel wall is of interest because ROS play important roles throughout atherogenesis.
In early atherosclerosis ROS stimulate vascular smooth muscle cell (VSMC) growth, while in late stages of lesion development ROS induce VSMC apoptosis causing atherosclerotic plaque instability.
To identify putative protective genes against oxidative stress, mouse aortic VSMC were infected with a retroviral human heart cDNA expression library and apoptosis was induced in virus-infected cells by DMNQ ( In addition, PP1cγ1 overexpression attenuated DMNQ-induced caspase-3/7 activation and DNA fragmentation. Inhibition of p53 protein expression using small interfering RNA abrogated DMNQ-induced Bax expression and significantly attenuated VSMC apoptosis. Together, these data indicate that PP1cγ1 overexpression promotes VSMC survival by interfering with JNK1 and p53 phosphorylation cascades involved in apoptosis.
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Enhanced reactive oxygen species (ROS) generation plays an important role in the proliferation, migration or apoptosis of vascular smooth muscle cells (VSMC), all of which have been implicated in the pathophysiology of vascular diseases including atherosclerosis. VSMC proliferation and migration are important in the development of atherosclerotic lesions and VSMC apoptosis is a histologic hallmark of advanced atherosclerosis (1) . Additionally, human VSMC isolated from coronary plaques are more susceptible to apoptosis than VSMC isolated from normal arteries (2) . Apoptosis of VSMC in atherosclerotic plaques is accompanied by numerous other events that increase the likelihood of plaque rupture. These include decreases in collagen and extracellular matrix protein production, decreased fibrous cap thickness, accumulation of macrophages along the shoulder of the plaque and increases in the size of the necrotic core and amount of cellular debris within the plaque (3) .
A better understanding of the mechanisms that regulate VSMC apoptosis could lead to the development of strategies to stabilize atherosclerotic plaques.
Identifying genes that could protect cells against oxidative stress requires selection of an oxidant and a screening strategy. A number of different approaches have been used to induce oxidative stress in cultured cells and in vivo. The quinones are of particular interest. Quinones are ubiquitous in nature and are also formed as metabolites from a variety of drugs, environmental pollutants and food derivatives by the action of cytochrome P450 system (4) . The redoxcycling 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) has been proposed as a model quinone compound to study the role of ROS in cell toxicity and apoptosis (5) . It does not react with free thiol groups, is nonalkylating and nonadduct-forming.
One-electron reduction of DMNQ by flavoenzymes such as NADPH-cytochrome P450 reductase or NADH-cytochrome b 5 reductase yields a semiquinone radical, which then reacts with oxygen to form superoxide (O 2 .-) and subsequently, the dismutation product H 2 O 2 . An obligatory two-electron reducing cytosolic flavoenzyme NADPH oxidoreducatse 1, also known as DT-diaphorase, can compete with one-electron reductases for DMNQ to produce a hydroquinone, which can undergo autooxidation to yield H 2 O 2 and the parental quinone.
Retroviral cDNA expression library screening has been used successfully to identify novel oncogenes (6) and modulators of apoptosis (7, 8) . The packaging cell lines used in conjunction with retroviral vectors generate high concentrations of infectious virus particles necessary for the efficient infection of large cell populations including that of primary cells with a single copy of vector per cell (9) . In addition, retroviral delivery systems have the ability to deliver very large libraries to infected cell populations. These properties make retroviral cDNA expression library screening an ideal strategy to identify genes that protect against oxidative stress.
Protein phosphorylation and dephosphorylation play an important regulatory role in apoptosis and other cellular processes (10) (11) (12) . Protein phosphatase 1 (PP1), 2A (PP2A), 2B (PP2B) and 2C (PP2C) are the four major serine /theronine phosphatases present in eukaryotic cells (13) . Of these four, PP1 and PP2A account for the majority of cellular phosphatase activity (13) . The catalytic subunit of PP1 exists in four different isoforms (α, γ1, γ2 and δ), which are targeted to various subcellular compartments by association with distinct regulatory proteins (14, 15) . The interaction of targeting proteins with the catalytic subunit also modulates substrate specificity enabling unique and independent roles for the various isoforms in regulating discrete cellular processes (15) .
Okadaic acid, a potent inhibitor of PP1 and PP2A, induces apoptosis in several cells and this was attributed to its preferential inhibition of one or other isoform depending on the cell type (16) (17) (18) (19) . Okadaic acidinduced epithelial cell apoptosis and inhibition of PP1 were correlated with increased expression of tumor suppressor gene p53 and proapoptotic gene Bax (19) . Serine phosphorylation in both the carboxyl-terminal and N-terminal domains modulates DNA binding ability and transcriptional activity of p53 (20, 21) . It has been shown recently that direct dephosphorylation of p53 at Ser15 and PP1cγ1 regulates apoptosis in vascular smooth muscle cells Ser37 by PP1 affects its stability, transcriptional and apoptotic activities (22, 23) .
Among the kinases that regulate the p53 pathway are JNK (c-Jun NH 2 -terminal kinase) group of mitogen-activated protein (MAP) kinases. JNKs are activated in cells exposed to various environmental stresses (24) and reactive oxygen species (ROS) play an integral part in this activation (25) . The ten members of the JNK family are generated by alternative splicing of transcripts from JNK1, JNK2 and JNK3 genes (24) . JNK1 and JNK2 double knockout cells are resistant to apoptosis induced by UV, anisomycin or DNA damage (26) . Proapoptotic proteins Bax and Bak are necessary for JNK-induced apoptosis and Bax remains inactive in JNK-deficient fibroblasts exposed to environmental stress (27) .
JNK is activated by dual phosphorylation at Thr 183 and Tyr 185 residues (24), which are dephosphorylated by dualspecificity MAP kinase phosphatases (28) .
In this study, we used retroviralmediated insertion of a human heart cDNA library into mouse aortic vascular smooth muscle cells (VSMC) to create DMNQresistant cell clones. The clones contained 17 full-length cDNAs. We chose to investigate the role of protein phosphatase 1cγ1 (PP1cγ1) in oxidative stress resistance because the cDNA coding for this protein was present in several independent DMNQ-resistant VSMC clones and because of our continued interest in protein phosphorylation as a regulatory mechanism in atherosclerotic disease process in general and VSMC biology in particular. DMNQ treatment induced mitochondrial ROS production and decreased PP1cγ1activity in VSMC. Overexpression of PP1cγ1 decreased DMNQ-induced phosphorylation of JNK1, and p53 (Ser15) and protected against DMNQ-induced apoptosis.
Further, p53 siRNA transfection protected VSMC against DMNQ-induced apoptosis. Together, these results suggest PP1cγ1 may regulate molecular mechanisms that mediate VSMC apoptosis in atherosclerosis and restenosis. Cell Culture─Aortic VSMC were isolated from 4-month-old male C57BL/6 mice as previously described by us (29) . Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS) as described previously (30) . All experiments were conducted using VSMC between passages 4 and 11 that were growth arrested by incubation in DMEM containing 0.1% FBS for 72 h.
EXPERIMENTAL PROCEDURES
Quiesced VSMC were treated with 60 µM of DMNQ for 16 h. Single cell clones that survived the treatment were isolated by localized trypsinization using cloning cylinders (Sigma) and expanded using GMEM (the Glasgow modification of Eagle's medium) supplemented with 2 mM glutamine, 1 mM sodium pyruvate, 1x nonessential amino acids, 10% (v/v) fetal bovine serum, a 1:1000 dilution of β-mercaptoethanol stock solution (70 µl of β-mercaptoethanol in 20 ml of distilled water) and 500 units/ml of leukocyteinhibitory factor (Chemicon). Virus Production─A human heart cDNA expression library was constructed in a replication defective MMLV-based vector, pCFB (Stratagene).
The unidirectionally oriented cDNA library contained 1x10 6 primary clones and was amplified only once to ensure the best representation. Retrovirus was o C. The PCR products were purified using QIAquick PCR purification kit (Qiagen) and sequenced using the above mentioned primers. The PCR products were analyzed on agarose gels to determine the length of the cDNAs. into pQCXIP (BD Bioscienses) and pShuttle-CMV, respectively. The sequence of PP1cγ1 constructs was confirmed by restriction analysis and DNA sequencing. Retrovirus encoding PP1cγ1 cDNA was generated as described above. Adenovirus encoding PP1cγ1 cDNA was generated after homologous recombination of pShuttle-CMV containing PP1cγ1 cDNA with the adenoviral backbone plasmid pADEasy-1 in BJ5183 E. coli (Stratagene). The recombinant (LE1/E3-deficient) adenoviruses were propagated by the transfection of human embryonic kidney 293 cells using Lipofectamine (Invitrogen).
Construction of Recombinant Viruses─To
The virus was serially amplified and then purified using ViraBind Adenovirus Purification Kit (Cell Biolabs, Inc). A control adenovirus contained an identical adenovirus backbone with green fluorescent protein cDNA (Ad-GFP).
Two mouse pSM2 retroviral siRNAs for p53 and one retroviral scrambled siRNA construct were purchased from Open Biosystems. The sense sequences of p53 siRNA were: 5′-ACCAGTCTACTTCCCGCCATAA-3′ (RHS1764-9208347) and 5′-CCCACTACAAGTACATGTGTAA-3′ (RMM1766-98468519). Constructs were transfected into Phoenix-Eco cells for Assessment of Apoptosis─For detection of apoptosis, growth-arrested VSMC were harvested after 16 h treatment with 10 µM DMNQ.
Histone-associated DNA fragmentation in cell lysates was determined using Cell Death Detection ELISA PLUS kit (Roche Applied Science) in accordance with the manufacturer's instructions.
A TUNEL apoptosis detection kit (Upstate Biotechnology Inc.) was used to measure DNA fragmentation according to the manufacturer's protocol.
Briefly, following treatment the cells were fixed in 4% paraformaldehyde and permeabilized by incubating with 0.5% Tween-20 and 0.2% BSA for 15 min. Then, cells were incubated with a reaction mix containing biotin-dUTP and terminal deoxynucleotidyl transferase for 60 min. Transfer of biotin-dUTP to the free 3′-OH end of cleaved DNA was visualized by reaction with fluorescein-conjugated avidin (FITC-avidin) for 30 min and photographed by fluorescence microscopy. Cells were counterstained with propidium iodide.
Apoptosis was also assessed by measuring Caspase-3/7 activities using an Apo-ONE TM Homogeneous Caspase-3/7 Assay kit (Promega). Briefly, growtharrested VSMC were treated with 10 µM DMNQ for 6 h. The cells were lysed using bifunctional cell lysis/activity buffer which contained a profluorescent caspase-3/7 consensus substrate, rhodamine 110
After incubation at room temperature for 1 h, aliquots (150 µl) were transferred to a 96-well clear-bottom plate. Fluorescence was measured at an excitation wavelength of 485 nm and an emission wavelength of 535 nm using a WALLAC 1420 Multilabel Counter. Measurement of PP1cγ1 mRNA expression─Total RNA from VSMC that were either treated or untreated with DMNQ was extracted using RNeasy Micro Kit (Qiagen). Reverse transcription was performed with 1 µg of total RNA using TaqMan Reverse Transcription Reagents Kit (Applied Biosystems). PP1cγ1 Gene Expression Assay (catlog number MA00849631-s1) was purchased from Applied Biosystems. Real-time PCR was performed using the ABI PRISM 7900 HT Sequence Detection System and TaqMan PCR Master Mix according to the manufacturer's recommendations. Sequence Detection System software (v 2.1) (applied Biosystems) was used for raw data analysis. PP1cγ1 relative expression was calculated using Relative Expression Software Tool (31) and by normalization to 18s ribosomal expression. Measurement of JNK1 Activity─JNK1 activity was assayed as described elsewhere (32) . Statistical analysis─All numerical data are expressed as mean ± S.E. Data were analyzed with one-way analysis of variance (ANOVA) and post-hoc analysis was performed using Newman-Keuls test. Statistical significance was accepted at p < 0.05
RESULTS

Human
Heart cDNA Library Screening─ Genes that may confer resistance to oxidative stress were identified by screening mouse aortic VSMC infected with a replication-deficient retroviral cDNA library prepared from the human heart. Freshly prepared virus was used for library screening so as to ensure high transduction efficiency. The selection of an intracellular oxidant that is highly apoptotic (close to 100% cell death) is essential for efficient library expression screening for VSMC clones with an oxidative stress-resistant phenotype and for significantly decreasing false positives. In the present investigation, mouse aortic VSMC were incubated with apoptogenic DMNQ (33, 34) for 16 h at increasing concentrations. Ten to fifteen VSMC clones in a 150-mm dish resisted 60 µM DMNQ.
Characterization of VSMC Clones Resistant to DMNQ-induced Apoptosis─To identify cDNAs with an antiapoptotic effect against DMNQ, 1x10
7 VSMC were transduced with 2x10 6 infectious units (two times the size of the library) of retrovirus containing a human heart cDNA library. This strategy ensured that nearly the entire cDNA library is represented in the screening and more than 90% of the transduced cells contained one cDNA.
A total of 132 cell clones remained viable after treatment with 60 µM DMNQ and were able to form colonies on enriched GMEM. No viable colonies were recovered from the control-transduced cells. In order to identify retrovirally-introduced cDNAs responsible for the DMNQ-resistant phenotype of VSMC clones, PCR analysis of gDNA was performed using primers specific for the retrovirus vector. We identified a total of 17 different full-length cDNAs in DMNQresistant VSMC clones ( Table 1) .
Four of the 17 genes were previously shown to afford protection against oxidative stress whereas the remaining genes were not known to modulate either apoptosis or oxidative stress. For example, transcriptional down regulation of aldolase and other glycolytic enzymes was reported under oxidative stress conditions (35) . Further, increased expression of aldolase and enhanced resistance to apoptosis were observed in cancer cell lines with constitutive expression of HIF-1α (36) . Though the primary function of myoglobin (Myo) is cellular O 2 storage, it also acts as a ROS scavenger (37) . Myo -/-mouse hearts had significantly higher levels of ROS than wild-type hearts under ischemia/reperfusion conditions. Translationally controlled tumor protein (TCTP) protects mammalian cells against chemically induced apoptosis and cytotoxicity and its overexpression inhibited proapoptotic effector caspases (38) . Similarly, overexpression of heat shock protein 27 (Hsp27) protects cisplatin-induced apoptosis PP1cγ1 regulates apoptosis in vascular smooth muscle cells of mouse fibroblasts (39) and human ovarian tumor cells (40) . Interestingly, plasma Hsp27 levels were decreased in atherosclerotic patients compared with healthy subjects (41) and downregulation of this protein decreases VSMC resistance to proteolytically-induced apoptosis (42) .
We chose to further investigate PP1cγ1 because it was the most common cDNA expressed in VSMC resistant to DMNQ and because inhibitors of PP1cγ1 are proapoptotic (18, 19) , indicating a potential role for PP1cγ1 in protecting against apoptosis.
Verification of the Protective Effect of PP1cγ1
Overexpression Against DMNQ─DMNQ-resistant VSMC clones were not produced when cells were exposed to 60 µM DMNQ suggesting that spontaneous development of DMNQ resistance does not occur in VSMC and is an unlikely explanation for DMNQ resistance in PP1cγ1 overexpressing cells.
However, it was important to establish that PP1cγ1 overexpression in wild-type VSMC could create DMNQ resistance. Cell viability was reduced by approximately 67% and 99% in adenoviral GFP expressing VSMC treated with 10 and 50 µM DMNQ, respectively. Adenoviral overexpression of PP1cγ1 increased cell viability to approximately 55% and 28% in VSMC treated with 10 and 50 µM DMNQ (p < 0.001 for each concentration compared with adenoviral GFP expressing cells), respectively (Fig. 1) .
These data suggest that PP1cγ1 cDNA originally isolated from DMNQ-resistant VSMC clones was involved in interrupting the DMNQ-induced apoptotic signaling pathways in VSMC.
DMNQ Induces Mitochondrial ROS Production in VSMC─To characterize the protective effect of PP1cγ1 against DMNQinduced apoptosis in VSMC, we sought to determine the site of DMNQ-induced intracellular ROS production. First, the effect of DPI, an inhibitor of NADPH oxidase and other flavoprotein enzymes on DMNQ-induced ROS generation was examined by measuring DCF fluorescence. Compared with basal conditions, 10 µM DMNQ increased ROS production to about 1.8-fold (Fig. 2, A) (Fig. 3B) MitoCapture is a cationic dye that aggregates in the mitochondria of healthy cells giving off a bright red fluorescence whereas in apoptotic cells it remains in the cytoplasm in its monomeric form, fluorescing green. The control cells showed only faint green fluorescence but contained foci of red fluorescence in the cells (Fig. 3C) . DMNQ treatment for 15 h resulted in significant green fluorescence in the cytoplasm of VSMC and no red fluorescence, indicating an increase in mitochondrial permeability. Together, these data indicate DMNQ induces VSMC apoptosis through mitochondrial ROS-dependent mechanisms.
PP1cγ1 Activity is Attenuated by DMNQ, Other Inducers of Mitochondrial ROS and H 2 O 2 ─ Because our data suggest that overexpression of PP1cγ1 protects VSMC against DMNQ-induced apoptosis, we investigated whether DMNQ treatment inhibits the activity of PP1cγ1. Using immunoprecipitation and a Serine/Threonine Phosphatase Assay Kit from Molecular Probes, an approximately 22% decrease in PP1cγ1 activity (p < 0.05 compared with control) was observed at 2 h after treatment with 10 µM DMNQ (Fig. 4A) . PP1cγ1 activity decreased approximately 75% at 8 h (p <0.001 compared with control) after treatment with DMNQ. Next, we investigated whether other agonists that induce mitochondrial ROS production regulate PP1cγ1 activity in VSMC. PP1cγ1 activity was significantly decreased in VSMC at 4 and 0.5 h after treatment with 25 µg/ml antimycin A and 100 ng/ml leptin, respectively (p < 0.001) (Fig. 4, B and C) . To confirm that ROS regulate activity, PP1cγ1 immunoprecipitated from VSMC lysates was incubated with 200 µM H 2 O 2. The phosphatase activity was significantly inhibited 10 min after incubation with H 2 O 2 (p < 0.001) and remained inhibited during 60 min incubation (Fig. 4D) . Together, these data indicate that increased mitochondrial ROS production inactivates PP1cγ1 activity.
PP1cγ1 is Abundant in VSMC Mitochondria─The observation that PP1cγ1 activity is regulated by mitochondrial ROSdependent mechanisms raises the question whether the phosphatase is present in VSMC mitochondria.
Western blot analysis of subcellular fractions of VSMC homogenates demonstrated that PP1cγ1 is present both in cytosol and mitochondria, though it is more abundant in the later (Fig.  5A) .
DMNQ Attenuates VSMC PP1cγ1 Expression by Inducing Proteasomedependent DegradationTo further define the inhibitory effect of DMNQ on PP1cγ1, we investigated the steady-state protein levels of the phosphatase in VSMC by Western blot analysis of cell lysates. DMNQ treatment for 8 h decreased PP1cγ1 protein levels by approximately 59% (p < 0.001) (Fig. 5, B and C) . However, PP1cγ1 mRNA levels in VMSC were unaffected by DMNQ treatment indicating that decreased protein levels did not result from dysregulation of transcription (Fig. 5D) . Next, we examined whether the low levels of PP1cγ1 protein in DMNQ-treated VSMC were caused by enhanced proteasomemediated degradation. Pretreatment of VSMC with MG132, a proteasome inhibitor, partially but significantly (p < 0.001) attenuated the DMNQ-induced decrease in PP1cγ1 protein levels after 8 h treatment (Fig. 5, E and F) . This was observed in the absence of any change in PP1cγ1 mRNA levels (data not shown). Together, these data indicate that DMNQinduced decrease in PP1cγ1 expression is, in part, mediated by the activation of ubiqutin-proteasome pathway. PP1cγ1 regulates apoptosis in vascular smooth muscle cells proapototic gene Bax and expression and phosphorylation of tumor suppressor gene p53. A significant increase in JNK1 activity (p < 0.001) was observed using an immunocomplex kinase assay in control VSMC at 30 min after treatment with 10 µM DMNQ (Fig. 5, A and B) . JNK1 activity in response to DMNQ treatment was not significantly different between control VSMC and cells infected with a control virus expressing enhanced green fluorescent protein (AdGFP).
PP1cγ1 Overexpression Abrogates DMNQ-induced
However, adenoviral overexpression of PP1cγ1 (AdPP1cγ1) abrogated DMNQ-induced activation of JNK1 in VSMC (Fig. 5, A and B) . To determine whether the observed regulatory effect of PP1cγ1 overexpression on JNK1 activity was specific, we examined stimulation of ERK1/2 in VSMC treated with DMNQ in the presence and absence of PP1cγ1 overexpression. ERK1/2 phosphorylation was significantly enhanced in VSMC after DMNQ treatment (Fig. 6C) and adenoviral overexpression of PP1cγ1 had no inhibitory effect on DMNQ-induced ERK1/2 phosphorylation.
Western blot analysis of cell lysates using phosphospecific antibody showed a significant increase in phosphorylation at Ser15 of p53 in control VSMC (p < 0.001) after 2 h treatment with DMNQ (Fig. 5, D  upper panel and E) . Similarly, a significant increase in p53 Ser15 phosphorylation (P<0.01) was observed in AdGFP VSMC treated with DMNQ compared with untreated AdGFP VSMC. Similar to its effect on JNK1, adenoviral overexpression of PP1cγ1 abrogated DMNQ-induced phosphorylation of p53 (Ser 15) in VSMC. Interestingly, control and AdGFP VSMC tend to have higher p53 protein expression levels after DMNQ treatment compared with their respective untreated controls (Fig. 5D, second panel and  F) . However, the increase in p53 protein expression in these two groups was not statistically significant. The expression of p53 protein in AdPP1cγ1 VSMC did not change after DMNQ treatment.
Because Bax expression is regulated by both JNK1 (44) and p53 (45), we determined the effect of DMNQ on Bax levels in VSMC. An approximately 10-fold increase in Bax protein level was observed in VSMC treated with 10 µM DMNQ for 6 h (Fig. 5, G  and H) . A similar increase in Bax expression was observed in AdGFP VSMC after DMNQ treatment. However, PP1cγ1 overexpression completely inhibited DMNQ-induced Bax protein level in VSMC. Together, these data indicate that high levels of PP1cγ1 protects VSMC against oxidative stress-induced apoptosis by specifically interfering with JNK1 and p53 activation.
PP1cγ1 Activity and Expression Regulate VSMC Apoptosis─Because suppression of PP1cγ1 activity and expression are correlated with DMNQinduced VSMC apoptosis and its overexpression increases the viability of VSMC treated with DMNQ, it is necessary to determine the physiological effect of suppression of endogenous PP1cγ1 on VSMC survival. Okadaic acid, a potent protein phosphatase inhibitor, suppresses PP2A activity at 20 nM, whereas it inhibits both PP1 and PP2A activities at 100 nM concentration (19). Treatment of VSMC with 100 nM okadaic acid for 12 h significantly increased histone-associated DNA fragmentation in VSMC (p < 0.001 compared with control), whereas 20 nM okadaic acid had no such effect (Fig. 7A) . Further, okadaic acid had an additive effect on DMNQ-induced VSMC apoptosis.
To complement the data that pharmacological inhibitor of PP1 activity induce apoptosis, we have used retroviral expression of PP1cγ1 shRNA to specifically silence the expression of endogenous PP1cγ1 in VSMC. Infection of mouse aortic VSMC with retroviral PP1cγ1 shRNA construct decreased PP1cγ1 expression by approximately 80% compared with cells infected with retroviral scrambled shRNA construct (Fig. 7B) .
Consistent with induction of apoptosis by okadaic acid, expression of PP1cγ1 shRNA significantly enhanced histone-associated DNA fragmentation in VSMC compared with cells expressing scrambled shRNA (Fig.  7C) (Fig. 7D) . Adenoviral overexpression of PP1cγ1 significantly attenuated (p < 0.001) DMNQ-induced caspase-3/7 activity in VSMC compared with that in DMNQ-treated AdGFP VSMC (Fig. 7D) .
Caspases function as effectors of apoptosis (48) and DNA fragmentation as well as nuclear morphological changes occur downstream of caspase activity (49, 50) . An approximately 8-fold increase in DNA fragmentation (p < 0.001) was observed in AdGFP VSMC after treatment with 10 µM DMNQ (Fig. 7E) . Adenoviral overexpression of PP1cγ1 in VSMC significantly attenuated (p < 0.001) DMNQ-induced DNA fragmentation compared with that in AdGFP VSMC treated with DMNQ (Fig. 7E) . Together, these data indicate that modulation of PP1cγ1 activity and expression regulates VSMC viability.
Silencing of p53 Expression by siRNA Abrogates DMNQ-induced Bax Protein Levels and Attenuates DMNQ-induced Apoptosis in
VSMC─To confirm the role of p53 in mediating apoptosis induced by DMNQ through inhibition of PP1cγ1, we have used retroviral expression of p53 shRNA to silence the expression of the endogenous p53. Infection of mouse aortic VSMC with retroviral p53 shRNA construct decreased p53 expression by approximately 85% compared with that in wild-type VSMC or cells infected with retroviral scrambled shRNA construct (Fig. 8A) . We next assessed the effect of expression of p53 shRNA on Bax protein levels in VSMC treated with 10 µM DMNQ for 6 h. Expression of p53 shRNA abrogated DMNQ-induced increase in Bax protein levels compared with that in cells expressing scrambled shRNA (Fig. 8, B and C) .
To determine if the observed abrogation of Bax expression in response to DMNQ treatment in retroviral p53 shRNA expressing cells resulted in decreased apoptosis, detection of nucleosomes in cell lysates was determined.
DMNQ-induced DNA fragmentation was significantly decreased (p < 0.001) in VSMC expressing p53 shRNA compared to that in cells expressing scrambled shRNA (Fig. 8D) . Consistent with this, VSMC infected with retroviral p53 shRNA showed low levels of TUNEL-positive cells (Fig. 8E) . In contrast, VSMC infected with retroviral scrambled shRNA displayed highly elevated levels of TUNEL-positive cells. Taken together, these results indicate PP1cγ1 expression regulates resistance to oxidant-induced apoptosis in VSMC by modulating p53-dependent cellular apoptotic pathways.
DISCUSSION
The present study was initiated to identify genes that impart resistance to oxidative stress in VSMC. Using retrovirusmediated cDNA library expression screening, we identified PP1cγ1 and 16 other genes that protected VSMC against DMNQ toxicity. Our data illustrate that PP1cγ1 attenuates VSMC apoptosis by abrogating DMNQ-induced JNK1 activation, p53 phosphorylation and Bax expression. Our results demonstrate a significant decrease in PP1cγ1 activity and expression in VSMC treated with DMNQ. We attribute the decrease in PP1cγ1 activity to increased mitochondrial ROS production upon DMNQ treatment. This observation is supported by our data that PP1cγ1 activity is also decreased in VSMC treated with antimycin and leptin, known inducer of mitochondrial ROS production (58,59). The redox-sensitive regulation of PP1cγ1 activity is also evident from significant inhibition of its activity in the presence of H 2 O 2 (Fig. 4D) . It has been reported that other PP1 isoforms that possess highly homologous catalytic domains to PP1cγ1 undergo reactive site cysteine oxidation and inactivation by ROS (60).
Watanabe and Forman (5) reported that autoxidation of hydroquinone formed from two-electron reduction of DMNQ by NAD(P)H quinone oxidoreductase 1 yields most of the ROS generated in cells treated with low concentrations of DMNQ. In the present study, we did not observe any inhibition of DMNQ-induced ROS production in VSMC by inhibitors of various cellular oxidases (Fig. 2) . In contrast, all electron transport chain inhibitors attenuated DMNQ-induced ROS production in VSMC indicating enhanced mitochondrial ROS generation upon DMNQ treatment. Further support for increased mitochondrial ROS generation is evident from the bright yellow/orange fluorescence resulting from colocalization of MitoTracker Green and MitoSox Red in the mitochondria of VSMC treated with DMNQ. Therefore, ROS production occurs predominantly in mitochondria of VSMC treated with DMNQ. Similarly, an increase in mitochondrial ROS generation was observed in pancreatic acinar cells treated with menadione, another naphthoquinone (61). However, redox-cycling of DMNQ might induce ROS production in the cytosol (5). The presence of PP1cγ1 in both the cytosol and mitochondria (Fig. 5A) makes it a target of increased ROS levels in the cytosol and mitochondria of VSMC treated with DMNQ.
In addition to decreasing activity, DMNQ also decreased PP1cγ1 protein levels in VSMC. However, decrease in PP1cγ1 protein levels did not result from decreased mRNA levels. Although decrease in protein levels could result from decreased translation of mRNA, our data indicate that proteasome-mediated degradation partially contributes to lower PP1cγ1 levels observed at 8 h after DMNQ treatment. The ability of DMNQ to induce proteasome-dependent degradation of proteins has been reported recently (62) .
The activation of caspases is a central step in the apoptosis signaling cascade and caspases transduce regulatory upstream signals into the cell death execution machinery (46) . Jänicke et al. (49) demonstrated that caspase-3 is required for DNA fragmentation that accompanies apoptosis. Caspase-3 activates an endonuclease, CAD, responsible for fragmentation of the DNA at the linker region between nucleosomes by inactivating ICAD (DEF45), the inhibitor of CAD (50, 63) . Consistent with previous observations (34, 61) , DMNQ at 10 µM concentration caused significant increase in caspase-3/7 activity and DNA fragmentation at 8 and 16 h after treatment. Caspase-3 was shown to disrupt the functions of complex I and II of the electron transport chain, resulting in loss of mitochondrial transmembrane potential and generation of ROS (64) . Indeed, we observed a significant decrease in mitochondrial transmembrane potential of VSMC treated with DMNQ.
A major conclusion of our study is that PP1cγ1 has a pro-survival function in the response of VSMC to oxidative stress and decrease in its activity and expression results in apoptosis. This notion is supported by our observation that okadaic acid, at a concentration (100 nM) known to inhibit PP1 activity, significantly increased VSMC apoptosis. Further, DMNQ exerted an additive effect on VSMC apoptosis in the presence of okadaic acid. Importantly, suppression of PP1cγ1 expression significantly enhanced basal as well as DMNQ-induced apoptosis in VSMC. Then, how could PP1cγ1 overexpression protects VSMC against DMNQ-induced oxidative stress?
One putative mechanism for increased survival of DMNQ-treated VSMC overexpressing PP1cγ1 could be interruption of JNK1 cascade. JNK1 activation has been implicated in apoptosis (24) and was shown to be necessary for the release of cytochrome c from the mitochondria (26) . Further, JNK1 is upstream of caspase-3 activation in apoptosis induced by several stressors (65, 66) . Consistent with the observation of Ramachandran et al. (34) , a significant increase in JNK1 activity was observed in DMNQ-treated VSMC in the present investigation.
However, PP1cγ1 overexpression abrogated DMNQ-induced JNK1 activity. This data is supported by a recent report that inhibition of PP1 leads to phosphorylation and activation of JNK1 in cancer cells and PP1 directly inactivates JNK1 in vitro (67) . It is noteworthy that suppression of JNK1 provides significant protection against apoptosis (25) .
JNK1 is known to phosphorylate p53 resulting in p53 accumulation and activation as a transcriptional regulator (68, 69) . p53, a master regulator of apoptosis regulates cell death by two mechanisms1) by transcriptional regulation of expression of genes involved in apoptosis (70, 71) ; 2) by activation of Bax in mitochondria to antagonize Bcl-2 and Bcl-XL, the antiapoptotic genes (72) . The transcriptional activity of p53 is regulated by several posttranslational mechanisms including phosphorylation/dephosphorylation, acetylation/deacetylation, ubiquitylation, sumoylation and glycosylation (23, 73, 74) . Phosphorylation and dephosphorylation impact both stability and function of p53 (73, 74) .
Consistent with DMNQ-induced apoptosis, we observed increased phosphorylation of p53 at Ser15 in DMNQtreated VSMC lysates. The increase in p53 Ser15 phosphorylation was abrogated by overexpression of PP1cγ1. These results are supported by an observation that PP1 dephosphorylates p53 at Ser15 and Ser37 in in vitro and in vivo dephosphorylation assays and PP1 promotes cell survival by negatively regulating p53-dependent death pathway (23) .
Consistent with the report of Sandau et al. (37), we observed increased Bax expression in VSMC treated with DMNQ. p53 was shown to upregulate Bax expression by binding to the regulatory region of the gene (45) . Alternatively, JNK can enhance the expression of Bax by either increasing AP-1 activity (75) or by stabilizing the protein (44) . Bax is located in the cytosol but inserts into mitochondrial membrane after an apoptotic signal (76) . Again, JNK can promote the translocation of Bax to mitochondria through phosphorylation of 14-3-3 protein, a cytoplasmic anchor of Bax (77) . It has been suggested that mitochondrial Bax associates with components of the mitochondrial permeability transition pore to cause loss of mitochondrial membrane potential. In fact, Bax translocation from the cytosol to the mitochondria was observed during DMNQinduced apoptosis (78) . Complementary to the reports that inhibition of PP1 induces the expression of p53 and Bax (19) , PP1cγ1 overexpression abrogated DMNQ-induced Bax expression in VSMC. Consistent with this, PP1cγ1 overexpression attenuated DMNQ-induced caspase 3/7 activity and DNA fragmentation in VSMC. Further, p53 siRNA abrogated DMNQ-induced Bax expression and attenuated DMNQ-induced apoptosis confirming that PP1cγ1 negatively regulates VSMC apoptosis cascades by modulating p53 phosphorylation.
In conclusion, our results demonstrate that PP1cγ1 attenuates DMNQ-induced VSMC apoptosis by abrogating JNK1 and p53 Ser15 phosphorylation. It is possible that dephosphorylation of other phosphoproteins by PP1cγ1 might play role in survival of VSMC under oxidative stress conditions. This finding supports further investigation of PP1cγ1 expression in restenosis and atherosclerosis as VSMC apoptosis profoundly affects these arterial diseases. Fig. 1 . Overexpression of PP1cγ1 increases VSMC viability after DMNQ treatment. VSMC infected with AdGFP or AdPP1cγ1 were quiesced for 3 days and treated with 10 or 50 µM DMNQ or vehicle for 16 h. Cell viability was determined by crystal violet staining. Data presented are mean + S.E. of three independent experiments (* and **, p < 0.001 compared with respective DMNQ-treated AdGFP VSMC). C, Densitometric analysis of PP1cγ1 protein levels (mean ± S.E., n = 3; * , p < 0.001 compared with control). D, Growth-arrested VSMC were treated with 10 µM DMNQ for the indicated times and the relative expression of PP1cγ1 mRNA was assayed by real-time PCR. PP1cγ1 mRNA expression was normalized to 18s rRNA (mean ± S.E., n = 3). E, Growth-arrested VSMC were pretreated with 5 µM MG132 for 2 h and then treated with DMNQ for the indicated times. Cell lysates were analyzed by Western blotting with anti-PP1cγ1 antibody or anti-β-actin antibody. F, Densitometric analysis of PP1cγ1 protein levels (mean ± S.E., n = 3; * , p < 0.001 compared with the respective control). * and ** , p < 0.001 and p < 0.01, respectively compared with their controls). F, Densitometric analysis of p53 protein levels. G, Cell lysates from untreated and DMNQ-treated VSMC were analyzed by Western blotting with anti-Bax, antiPP1cγ1or anti-β-actin antibodies. H, Densitometric analysis of p53 protein levels (mean ± S.E., n = 3; * , p < 0.001 compared with untreated VSMC). --+  ----Proadifen  ---+  ---Phenelzine  ----+  --Indomethacin  -----+  -NDGA  ----- 
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